MYOMO, INC. (MYO) research
MYOMO, INC.- Sector
- Healthcare
- Industry
- Medical Devices
- Last price
- $1.63
- As of
MYOMO, INC. (MYO): 4 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-08-05.
As of . Source: SEC EDGAR filings for MYO. Method and limitations.
Share the MYO intelligence card
See the full MYO dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for MYO on one page. Preview it with sample data, then open it live with a free account.
Preview the MYO dossierActive signals for MYO
- highCONSENSUS_BUY
4 tracked funds increased MYO this 2026Q2, institutional consensus
- mediumNEW_POSITION
Point72 Asset Management, L.P. new position in MYO
- mediumNEW_POSITION
MILLENNIUM MANAGEMENT LLC new position in MYO
- highINSTITUTIONAL_SURGE
RENAISSANCE TECHNOLOGIES LLC added +106% to MYO (2026Q2)
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +188% to MYO (2026Q2)
FREE, NO ACCOUNT
Every signal on MYO, as it fires
You are seeing 5 of 10 signals recorded on MYO since 2026-06-02.
The five above landed across 2 days. The other 5 were recorded on 3 other days. 5 of the 10 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in MYO (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| MILLENNIUM MANAGEMENT LLCCUSIP 62857J201 · 2026Q2 | $282K | 0.00% | , |
| CITADEL ADVISORS LLCCUSIP 62857J201 · 2026Q2 | $107K | 0.00% | , |
| RENAISSANCE TECHNOLOGIES LLCCUSIP 62857J201 · 2026Q2 | $50K | 0.00% | , |
| Point72 Asset Management, L.P.CUSIP 62857J201 · 2026Q2 | $21K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, MYO
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
MYO against its peers
MYO's operating margin of -35.2% ranks in the 73rd percentile of 23 Medical Devices sub-industry peers, fiscal periods ending between 2025-12-31 and 2026-06-30.
| Metric | MYO | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 40.9M USD | 32.0M USD | 60 | 23 |
| Gross margin | 65.7% | 53.2% | 66 | 18 |
| Operating margin | -35.2% | -55.8% | 73 | 23 |
| Net margin | -38.1% | -59.7% | 65 | 23 |
| Return on equity | -136.6% | -70.9% | 23 | 19 |
Peers (23): POSC, MDNC, OM, TELA, RPID, COCH, MDAI, XTNT, ZOMDF, NNOX, SRTS, SERA, LUNG, LNSR, CVRX, HYPR, SNWV, ECOR, PAVM, ELUT, QTI, ARAY, APYX. Left out: RTGN (no annual filing), TLTFF (no annual filing). Fiscal periods ending between 2025-12-31 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (MYO: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
See more MYO signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to MYOand get the insider, 13F, options, and confluence read in one view.